Keyword: GlaxoSmithKline (GSK)

News

European Companies Catch A Cold In Emerging Markets

07.08.2013 - Times are getting tough for European firms in emerging markets where HSBC talks of a cyclical "slowdown", Diageo sees "choppy conditions" and Unilever views deceleration as the...

News

India Revokes GSK Cancer Drug Patent In Latest Big Pharma Blow

05.08.2013 - India has revoked a patent granted to GlaxoSmithKline for breast cancer drug Tykerb, a decision that follows a landmark India court ruling disallowing patents for incremental...

News

Drug Makers Fear Short-Term Turmoil As China Probes Widen

02.08.2013 - Chinese authorities visited a regional office of French drugmaker Sanofi this week in the latest sign of a widening investigation into Western drugmakers. Eli Lilly said it had...

News

AstraZeneca Warns Of Higher Costs As Drug Sales Slide

02.08.2013 - British drugmaker AstraZeneca warned on Thursday of higher costs in 2013 as it invests through a slump in sales caused by a wave of patent expiries on key medicines. The prediction...

News

Bayer Divestment of its MaterialScience Unit ‘Inevitable,’ Analysts Say

30.07.2013 - Expectations that Bayer will embrace a trend in the pharma sector to split off non-core units may be too far ahead of the curve. The diversified German healthcare group has an...

News

Why China Pays Over The Odds For Its Medicines

29.07.2013 - China has a drug problem. While most Western countries spend 10-12% of their healthcare budget on medicines, in China it is well over 40%, a disparity that goes to the heart of...

News

Europe Backs New Dual-Action Novartis Lung Drug

29.07.2013 - Swiss drugmaker Novartis won an important endorsement of its new inhaled medicine for chronic lung disease on Friday when European regulators recommended approval of Ultibro...

News

Foreign Pharma Companies Could Be Probed In China

25.07.2013 - China's official news agency hinted that more foreign pharmaceutical firms could soon be implicated in a corruption scandal sweeping the industry, in the wake of bribery...